1. Home
  2. ROIV vs CAE Comparison

ROIV vs CAE Comparison

Compare ROIV & CAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$28.34

Market Cap

20.7B

Sector

Health Care

ML Signal

HOLD

Logo CAE Inc.

CAE

CAE Inc.

HOLD

Current Price

$27.94

Market Cap

10.1B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROIV
CAE
Founded
2014
1947
Country
United Kingdom
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.7B
10.1B
IPO Year
2021
2002

Fundamental Metrics

Financial Performance
Metric
ROIV
CAE
Price
$28.34
$27.94
Analyst Decision
Strong Buy
Buy
Analyst Count
8
3
Target Price
$27.56
$34.33
AVG Volume (30 Days)
4.7M
627.5K
Earning Date
05-11-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$29,053,000.00
N/A
Revenue This Year
N/A
$5.29
Revenue Next Year
$385.85
N/A
P/E Ratio
N/A
$35.13
Revenue Growth
N/A
N/A
52 Week Low
$8.73
$20.36
52 Week High
$30.33
$34.24

Technical Indicators

Market Signals
Indicator
ROIV
CAE
Relative Strength Index (RSI) 54.64 39.14
Support Level $26.94 $27.53
Resistance Level N/A $29.71
Average True Range (ATR) 1.01 0.84
MACD -0.26 -0.18
Stochastic Oscillator 38.46 24.82

Price Performance

Historical Comparison
ROIV
CAE

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About CAE CAE Inc.

CAE Inc provides training and aviation services, integrated enterprise solutions, in-service support, and crew-sourcing services. The company operations are managed through two segments: Civil Aviation which offers comprehensive training solutions for flight, cabin, maintenance, and ground personnel in commercial, business, and helicopter aviation, a complete range of flight simulation training devices, ab initio pilot training, and crew sourcing services, as well as aircraft flight operations solutions; and Defense and Security which is a world-wide training and simulation provider delivering scalable, platform-independent solutions that enable and enhance force readiness and security. It generates the majority of its revenue from the Civil Aviation segment.

Share on Social Networks: